Science News & Science Current Events
 

Cancer-causing Agents Current Events | Cancer-causing Agents News

Page 1 of 122 | 3041 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Fat transforms vitamin C from 'good cop' into 'bad cop'
Fat in the stomach may cause vitamin C to promote, rather than prevent, the formation of certain cancer causing chemicals, reveals research published ahead of print in the journal Gut.   view more (2007-09-04)

Researchers Discover New Method to Treat Cancer
Research at Oxford University's Institute of Molecular Medicine has identified a novel therapeutic regimen for the treatment of cancer that provides significant advantages over the existing methods of cancer treatment. There are already a number of regimens available for treatment of cancer,... view more (2003-03-20)

New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks
A drug that targets the cell surface receptors that play an important role in many types of cancer can bring about significant tumour regression in breast cancer after only six weeks of use.   view more (2008-04-17)

Air pollution may increase lung cancer risk
Chronic air pollution may increase the risk of lung cancer, suggests a Norwegian study of over 16,000 men in Thorax. Researchers monitored the health of 16, 209 men from 1972 until 1998. The men, all of whom lived in Oslo, were taking part in long term research on risk factors for heart disease and... view more (2003-12-03)

UC Davis researchers discover genetic switch involved in cells' response to radiation therapy
UC Davis Cancer Center researchers have discovered a genetic switch that causes cancer cells to become more sensitive to a drug administered to enhance radiation therapy effectiveness.   view more (2005-11-17)

New compound may protect against liver cancer
Researchers have identified a new compound called CDDO-Im that protects against the development of liver cancer in laboratory animals.   view more (2006-02-15)

Chemotherapy causes delayed severe neural damage
Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as "chemobrain" - that may compromise the quality of life of a proportion of cancer survivors.   view more (2008-04-22)

Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer
Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported today at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines. The team is currently... view more (2008-04-14)

Synergistic growth inhibitory effect of herbal extracts against HCC and lung cancer cells
Several herbs with diversified pharmacological properties are known to be rich sources of chemical constituents that may have potential for the treatment of several human cancers. Data from the Department of Preclinical Science, Faculty of Medicine, Thammasat University, demonstrates that the... view more (2008-04-30)

VEGF Trap shows activity in patients with advanced ovarian cancer
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.   view more (2007-06-04)

Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus:
Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus:   view more (1999-08-11)

Researchers discover link between organ transplantation and increased cancer risk
Researchers have determined a novel mechanism through which organ transplantation often leads to cancer, and their findings suggest that targeted therapies may reduce or prevent that risk.   view more (2008-07-16)

U of Saskatchewan distinguished researcher finds an SOS response to cancer-causing agents
University of Saskatchewan microbiologist Wei Xiao has found a way to trigger a protein combination called 9-1-1 that sends an SOS signal for cells to fight cancer-causing agents such as industrial toxins, ultraviolet radiation, and X-rays.   view more (2008-05-16)

Newer contrast agents safe for children
Allergic-like reactions to newer iodine-containing contrast agents (nonionic contrast media), are rare in children according to a recent study conducted by researchers from the University of Michigan Medical Center and C.S. Mott Children's Hospital both in Ann Arbor.   view more (2007-06-08)

Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
Mayo Clinic Cancer Center researchers have found that chaetocin, a by-product of a common wood mold, has promise as a new anti-myeloma agent.   view more (2007-04-16)

Analysis of breast-cancer gene role offers promising target
Researchers at UT Southwestern Medical Center have for the first time described how multiple copies of a gene are responsible for metastases in early-stage breast cancer and poor prognosis for patients.   view more (2006-10-31)

Jefferson scientists show gene reverts cancer genes to normal, predicts breast cancer prognosis
Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have shown that the activity of a gene that commandeers other cancer-causing genes, returning them to normal, can predict the prognosis of an individual with breast cancer.   view more (2006-11-01)

Scientists discover how body fights to control spread of cancer
Scientists at the University of Liverpool have found how two molecules fight in the blood to control the spread of cancer cells.   view more (2007-01-09)

HtrA1 and resistance to chemotherapy in ovarian and gastric cancers
While many cancer patients initially have a favorable response to chemotherapy for the treatment of solid tumors, resistance to treatment often develops.   view more (2006-06-09)

Biosensor sniffs out explosives
Temple University School of Medicine researchers have developed a new biosensor that sniffs out explosives and could one day be used to detect landmines and deadly agents, such as sarin gas, according to a paper in the June issue of Nature Chemical Biology.   view more (2007-05-09)

Massey researchers induce cell death in leukemia
Researchers from the Virginia Commonwealth University Massey Cancer Center today presented preclinical research at the American Association of Cancer Research's annual meeting suggesting the potential of a new combination treatment for chronic lymphocytic leukemia (CLL).   view more (2007-04-17)

Chemotherapy can be more toxic to brain cells than to cancer cells and may cause brain damage
Drugs used to treat cancer may damage normal, healthy brain cells more than the cancer cells they are meant to target.   view more (2006-11-30)

Cancer therapy: A role for MAPK inhibitors combined with mTORC1 inhibitors
Nearly a decade ago, while it was being tested as an immunosuppressive agent to prevent organ rejection in transplant patients, the drug rapamycin was also discovered to have anti-tumor properties. Since then, several rapamycin analogs known as mTOR (mammalian target of rapamycin) inhibitors have... view more (2008-08-22)

NSAIDs: Painkillers, inflammation inhibitors, anti-cancer drugs and new de-methylating agents
Researchers at the National Sun Yat-Sen University and Kaohsiung Medical University, Kaohsiung, Taiwan have revealed a new mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) attenuate tumor invasion and metastasis.   view more (2008-03-27)

Gadonanotubes greatly outperform existing MRI contrast agents
Researchers at Rice University, the Baylor College of Medicine, the University of Houston and the Ecole Polytechnique Fédérale de Lausanne in Switzerland have created a new class of magnetic resonance imaging (MRI) contrast agents that are at least 40 times more effective... view more (2005-08-12)
Page 1 of 122 | 3041 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com